Cancer Research

How Does 3D DNA Structure Influence Gene Activity?
Research & Development How Does 3D DNA Structure Influence Gene Activity?

Picture the intricacies hidden within the cell—each nucleus containing a vast genome map, intricately folded into a complex three-dimensional (3D) shape. How does this hidden architecture influence the very essence of life, determining which genes are silent or expressed? The Importance of 3D DNA

MiNK's iNKT Therapies Promise Breakthroughs in Cancer Treatment
Research & Development MiNK's iNKT Therapies Promise Breakthroughs in Cancer Treatment

The field of cancer treatment is witnessing seismic shifts as MiNK Therapeutics, a clinical-stage biotechnology firm and subsidiary of Agenus Inc., introduces groundbreaking cell-based therapies focused on treating challenging cancers. With its pioneering work on invariant natural killer T (iNKT)

Will Expanded Kisqali Access Transform Early Breast Cancer Care?
Management & Regulatory Will Expanded Kisqali Access Transform Early Breast Cancer Care?

In the dynamic world of biopharma, few individuals possess as vast an understanding of technology and innovation in the field as Ivan Kairatov. With a solid background in research and development, Ivan offers invaluable insights into the recent advancements and decisions impacting the

NeoVaxMI Trial Shows Enhanced Immune Response in Melanoma
Research & Development NeoVaxMI Trial Shows Enhanced Immune Response in Melanoma

The rapid evolution of personalized cancer vaccines promises a transformative era in oncology, as evidenced by the latest research on NeoVaxMI conducted by the Dana-Farber Cancer Institute. This study, focused on patients with untreated advanced or high-risk melanoma, explores advancements in the

Can Tevimbra Transform Nasopharyngeal Cancer Treatment?
Management & Regulatory Can Tevimbra Transform Nasopharyngeal Cancer Treatment?

Introducing Ivan Kairatov, a renowned Biopharma expert with an extensive background in technology, innovation, and research and development within the pharma industry. Ivan is here to discuss the recent European Commission approval of Tevimbra for nasopharyngeal cancer, a significant milestone in

Will Budget Cuts Derail NCI's Fight Against Cancer Progress?
Research & Development Will Budget Cuts Derail NCI's Fight Against Cancer Progress?

The escalating battle against cancer faces an unexpected obstacle as federal budget constraints threaten the stability of the National Cancer Institute (NCI), a critical player in this fight. How will these financial stringencies impact the groundbreaking work that has driven monumental progress in

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later